Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses

[1]  F.‐S. Liang.  catalytic nucleic acids , 2020 .

[2]  J. Vinjé,et al.  ICTV Virus Taxonomy Profile , 2019 .

[3]  S. Johnston,et al.  Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness , 2017, Journal of Allergy and Clinical Immunology.

[4]  T. Jartti,et al.  Role of viral infections in the development and exacerbation of asthma in children , 2017, Journal of Allergy and Clinical Immunology.

[5]  P. Simmonds,et al.  ICTV Virus Taxonomy Profile: Picornaviridae , 2017, The Journal of general virology.

[6]  N. Papadopoulos,et al.  Promising approaches for the treatment and prevention of viral respiratory illnesses , 2017, Journal of Allergy and Clinical Immunology.

[7]  C. Bachert,et al.  Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation , 2017, The Journal of allergy and clinical immunology.

[8]  M. Neurath,et al.  Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice. , 2017, Gastroenterology.

[9]  J. Gern,et al.  A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques , 2016, Nature Communications.

[10]  H. Renz,et al.  Antisense molecules: A new class of drugs. , 2016, The Journal of allergy and clinical immunology.

[11]  J. Gern,et al.  Rhinoviruses and Their Receptors: Implications for Allergic Disease , 2016, Current Allergy and Asthma Reports.

[12]  N. Krug,et al.  Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma. , 2015, The Journal of allergy and clinical immunology.

[13]  F. V. van Kuppeveld,et al.  Replication and Inhibitors of Enteroviruses and Parechoviruses , 2015, Viruses.

[14]  C. Bachert,et al.  Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. , 2015, The New England journal of medicine.

[15]  S. Johnston,et al.  Challenges in developing a cross-serotype rhinovirus vaccine. , 2015, Current opinion in virology.

[16]  C. Bachert,et al.  TMEM16A-Mediated Mucin Secretion in IL-13-Induced Nasal Epithelial Cells From Chronic Rhinosinusitis Patients , 2015, Allergy, asthma & immunology research.

[17]  J. Gern.  How rhinovirus infections cause exacerbations of asthma , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  J. Gern,et al.  Improved Molecular Typing Assay for Rhinovirus Species A, B, and C , 2014, Journal of Clinical Microbiology.

[19]  J. Kuhlmann,et al.  Biodistribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure in mice, rats and dogs. , 2013, Toxicology and applied pharmacology.

[20]  I. Mackay,et al.  Circularizing picornavirus genomes to rapidly obtain terminal sequence. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  B. Guy,et al.  Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid Protein , 2013, PLoS pathogens.

[22]  I. Mackay,et al.  From sneeze to wheeze: what we know about rhinovirus Cs. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[23]  P. Simmonds,et al.  Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types , 2013, The Journal of general virology.

[24]  S. Kauppinen,et al.  Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.

[25]  T. Hansen,et al.  Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposure. , 2013, Pulmonary pharmacology & therapeutics.

[26]  K. St. George,et al.  Human Rhinoviruses , 2013, Clinical Microbiology Reviews.

[27]  J. Gern,et al.  Clinical and molecular features of human rhinovirus C. , 2012, Microbes and infection.

[28]  P. Sly,et al.  Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment , 2012, Nature Medicine.

[29]  I. Pali-Schöll,et al.  Absence of unspecific innate immune cell activation by GATA-3-specific DNAzymes. , 2012, Nucleic acid therapeutics.

[30]  H. Goossens,et al.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists , 2012, Rhinology journal.

[31]  H. Goossens,et al.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. , 2012, Rhinology.

[32]  N. Papadopoulos,et al.  Misdirected antibody responses against an N‐terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  M. Parker,et al.  An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus. , 2012, ACS medicinal chemistry letters.

[34]  W. Carman,et al.  During the summer 2009 outbreak of "swine flu" in Scotland what respiratory pathogens were diagnosed as H1N1/2009? , 2011, BMC infectious diseases.

[35]  T. Jartti,et al.  Rhinovirus‐induced bronchiolitis and asthma development , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[36]  A. Chang,et al.  Usefulness of Published PCR Primers in Detecting Human Rhinovirus Infection , 2011, Emerging infectious diseases.

[37]  P. Simmonds,et al.  Proposals for the classification of human rhinovirus species C into genotypically assigned types. , 2010, The Journal of general virology.

[38]  A. Chang,et al.  Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital , 2010, Journal of medical virology.

[39]  S. Liggett,et al.  Analysis of the complete genome sequences of human rhinovirus , 2010, Journal of Allergy and Clinical Immunology.

[40]  J. Gern.  The ABCs of Rhinoviruses, Wheezing, and Asthma , 2010, Journal of Virology.

[41]  S. Johnston,et al.  Azithromycin induces anti-viral responses in bronchial epithelial cells , 2010, European Respiratory Journal.

[42]  I. Mackay,et al.  Newly identified human rhinoviruses: molecular methods heat up the cold viruses , 2010, Reviews in medical virology.

[43]  I. Mackay,et al.  Human rhinoviruses: coming in from the cold , 2009, Genome Medicine.

[44]  David Spiro,et al.  Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution , 2009, Science.

[45]  D. Barton,et al.  Cis-active RNA elements (CREs) and picornavirus RNA replication. , 2009, Virus research.

[46]  J. Gern.  Rhinovirus and the initiation of asthma , 2009, Current opinion in allergy and clinical immunology.

[47]  E. De Clercq,et al.  Selective inhibitors of picornavirus replication , 2008, Medicinal research reviews.

[48]  J. Lötvall,et al.  Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin‐8 release , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[49]  E. Zdobnov,et al.  The cis-acting replication elements define human enterovirus and rhinovirus species. , 2008, RNA.

[50]  D. A. Stein,et al.  A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus , 2008, Antimicrobial Agents and Chemotherapy.

[51]  S. Johnston,et al.  Role of respiratory viral infections in the development of atopic conditions , 2008, Current opinion in allergy and clinical immunology.

[52]  W. Henke,et al.  Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. , 2008, The Journal of allergy and clinical immunology.

[53]  R. Jackson,et al.  Internal initiation of translation from the human rhinovirus-2 internal ribosome entry site requires the binding of Unr to two distinct sites on the 5' untranslated region. , 2007, The Journal of general virology.

[54]  J. Carlin,et al.  Community Epidemiology of Human Metapneumovirus, Human Coronavirus NL63, and Other Respiratory Viruses in Healthy Preschool-Aged Children Using Parent-Collected Specimens , 2007, Pediatrics.

[55]  E. Zdobnov,et al.  New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features , 2007, BMC Genomics.

[56]  S. Johnston,et al.  Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma , 2007, Journal of Allergy and Clinical Immunology.

[57]  P. Gibson,et al.  Asthma exacerbations · 3: Pathogenesis , 2006, Thorax.

[58]  H. Wagner,et al.  All is not Toll: new pathways in DNA recognition , 2006, The Journal of experimental medicine.

[59]  S. Silverman.  In vitro selection, characterization, and application of deoxyribozymes that cleave RNA , 2005, Nucleic acids research.

[60]  N. Papadopoulos,et al.  Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells , 2005, Respiratory research.

[61]  W. Busse,et al.  The role of rhinovirus in asthma exacerbations. , 2005, The Journal of allergy and clinical immunology.

[62]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[63]  H. Kelly,et al.  Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002–2003 , 2004, Journal of medical virology.

[64]  L. Kalogjera,et al.  European Position Paper on Rhinosinusitis and Nasal Polyps , 2007 .

[65]  V. Erdmann,et al.  Gaining target access for deoxyribozymes. , 2004, Journal of molecular biology.

[66]  B. Heinz,et al.  Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism. , 2004, Antiviral research.

[67]  J. Wedzicha.  Role of viruses in exacerbations of chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.

[68]  V. Erdmann,et al.  RNA cleaving '10-23' DNAzymes with enhanced stability and activity. , 2003, Nucleic acids research.

[69]  M. Cairns,et al.  Catalytic DNA: a novel tool for gene suppression. , 2002, Current drug targets.

[70]  S. Akira,et al.  Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Cairns,et al.  Catalytic nucleic acids: from lab to applications. , 2000, Pharmacological reviews.

[72]  E. Murphy.  Mysteries of magnesium homeostasis. , 2000, Circulation research.

[73]  G. F. Joyce,et al.  Mechanism and utility of an RNA-cleaving DNA enzyme. , 1998, Biochemistry.

[74]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[75]  Hugh Pelham,et al.  Coming in from the cold , 2006, Nature.